Ever Source Wealth Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,002 shares of ARWR stock, worth $39,047. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,002
Previous 247
305.67%
Holding current value
$39,047
Previous $3,000
400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ARWR
# of Institutions
321Shares Held
99.5MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$611 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$605 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$413 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$248 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$204 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.12B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...